Clinical trials
Terminated Pulmonary Fibrosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| InterMune | 2 |
| Kyntra Bio | 2 |
| Ainos, Inc. (f/k/a Amarillo Biosciences Inc. | 1 |
| Alicia Gerke | 1 |
| Amgen | 1 |
| Aptabio Therapeutics, Inc. | 1 |
| Bellerophon Pulse Technologies | 1 |
| Corewell Health East | 1 |
| Joshua M Hare | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Fibrosis | 21 |
| Idiopathic Pulmonary Fibrosis | 13 |
| Lung Diseases, Interstitial | 8 |
| Fibrosis | 5 |
| Lung Diseases | 5 |
| Hypertension, Pulmonary | 3 |
| Idiopathic Interstitial Pneumonias | 3 |
| COVID-19 | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Albinism | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.